Cargando…
Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide
Diazoxide is a potential candidate for the treatment of transitional hypoglycaemia in infants. A clinical trial is currently underway to investigate whether low-dose oral diazoxide is beneficial for severe or recurrent transitional neonatal hypoglycaemia (the NeoGluCO Study, registration ANZCTR12620...
Autores principales: | Purohit, Trusha J., Laing, Don, McKinlay, Christopher JD., Alsweiler, Jane M., Hanning, Sara M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559840/ https://www.ncbi.nlm.nih.gov/pubmed/37810084 http://dx.doi.org/10.1016/j.heliyon.2023.e20101 |
Ejemplares similares
-
Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial
por: Laing, Don, et al.
Publicado: (2022) -
Factors influencing glycaemic stability after neonatal hypoglycaemia and relationship to neurodevelopmental outcome
por: Burakevych, Nataliia, et al.
Publicado: (2019) -
Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial
por: Oliphant, Elizabeth Anne, et al.
Publicado: (2023) -
Continuous glucose monitoring in neonates: a review
por: McKinlay, Christopher J.D., et al.
Publicado: (2017) -
Associations between neonatal hypoglycaemia and brain volumes, cortical thickness and white matter microstructure in mid-childhood: An MRI study
por: Nivins, Samson, et al.
Publicado: (2022)